NCT07586826: Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
- State
- Under way
- Phase
- Phase 2
- People
- 220 planned
- Started
- 22 Dec 2025
- Primary completion
- 31 Oct 2027
- Arms
- Romiplostim N01 Plus ATRA
- Results
- None posted
- 22 Dec 2025: Trial started
- 14 May 2026: Trial registered